McDonnell Boehnen Hulbert & Berghoff LLP attorneys Kevin
Noonan, Ph.D., Jeremy Noe, Andrew Williams, Ph.D., Jeffrey Armstrong, Donald Zuhn Jr., Ph.D., James Lovsin and Aaron Gin, Ph.D. are cited in an October 2, 2017 Law360 article entitled, “IP Attys Back Regeneron Over Inequitable Conduct Finding.” Numerous intellectual property law organizations and lawyers are calling for the full Federal Circuit to review its panel decision affirming that a Regeneron Pharmaceuticals Inc. patent is unenforceable in part because of inequitable conduct of litigators during a later infringement case, arguing it could “seriously and negatively affect the course of patent prosecution.” view the article